New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ZeaVision's Zeaxanthin-Based Supplement Offers Hope To Macular Degeneration Patients And Their Families

ST. LOUIS, June 10 -- Each year, an estimated 500,000 people receive the heart-breaking diagnosis of macular degeneration, the leading cause of blindness in individuals age 55 and older. It's a particularly devastating diagnosis, because little can be done as the disease slowly robs patients of their precious sight and quality of life.

That is changing, however, as more is learned about zeaxanthin, a strong antioxidant with superior light-filtering properties and one of two yellow carotenoids in the retina. Studies have shown that zeaxanthin is preferentially absorbed from food and settles in the center of the macula. Now, a growing body of research suggests that increasing the level of zeaxanthin in the macula may slow and even prevent macular degeneration by providing a critical nutrient the eye needs to protect and possibly heal.

It is also the main ingredient in ZeaVision, a dietary supplement and the only product on the market shown to deliver sufficient levels of zeaxanthin to the macula. There, it helps protect the eye from the damaging effects of aging and sunlight.

"Essentially, ZeaVision acts like 'nature's sunglasses,' shielding the eyes while allowing them to repair and heal," says Dennis L. Gierhart, Ph.D., chairman and CEO of ZeaVision L.L.C. "For the 17 million already suffering from macular degeneration, that means new hope and the promise of a better quality of life -- hope that extends to the millions of others who face the very real possibility of developing this hereditary disease."

Available without a prescription, ZeaVision comes in two dosages: a 10 mg supplement for people who have been diagnosed with or are at increased risk for macular degeneration, and a 3 mg supplement for people at low or no risk who want to maintain healthy zeaxanthin levels.

"Zeaxanthin occurs naturally in foods such as corn, oranges, eggs and certain leafy green vegetables. Unfortunately, it's difficult to meet the body's requirements through diet alone, although doing so may be critical to eye health," says Steven N. Frank, vice chairman and president of ZeaVision. "Research has already demonstrated that zeaxanthin may help prevent macular degeneration, and a growing body of scientific evidence suggests that restoring zeaxanthin levels may slow the disease's progression. But further study is needed, and ZeaVision actively supports and participates in ongoing research."

ZeaVision has been extensively tested and found to be safe with no known side effects or drug interactions. It is available on the Company's website at or by calling toll-free (888) 875-EYES (3937).

About ZeaVision L.L.C.
Based in St. Louis, ZeaVision L.L.C. ( developed and markets ZeaVision, a dietary supplement containing zeaxanthin and formulated to help prevent and/or impede the progression of macular degeneration. The Company holds three U.S. patents on the ZeaVision formula, which is available without a prescription in both 10 mg and 3 mg supplements.

SOURCE ZeaVision L.L.C.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.